Design Therapeutics, Inc. Form D Notices of Exempt Offering of Securities
Notices filed with the SEC for securities sold without registration under Regulation D or Section 4(a)(5), newest first. Values are as filed.
- 2021-02-12: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale 2021-01-25; Total offering amount $125,000,063.
- 2020-06-03: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale 2020-02-21; Total offering amount $45,500,246.
- 2020-03-20: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale 2020-02-21; Total offering amount $45,500,246.
| Filed | Federal exemption | Types of securities offered | Date of first sale | Total offering amount | Total amount sold | Total remaining to be sold | Investors who have already invested |
|---|---|---|---|---|---|---|---|
| 2021-02-12 | Rule 506(b) | Equity | 2021-01-25 | $125,000,063 | $125,000,063 | $0 | 26 |
| 2020-06-03 D/A | Rule 506(b) | Equity | 2020-02-21 | $45,500,246 | $45,500,246 | $0 | 6 |
| 2020-03-20 | Rule 506(b) | Equity | 2020-02-21 | $45,500,246 | $45,500,246 | $0 | 6 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |